Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) announced Wednesday that it is divesting its subsidiary business, C³ Cannabinoid Compound Company GmbH, to Dermapharm Holding SE, a European pharmaceutical company headquartered in Grünwald, Germany. Deal Details The transaction includes an upfront payment of EUR 80 million ($90.24 million), which will be made upon closing of the transaction in addition to an earnout payment of up to EUR 42.6 million, subject to the achievement of select milestones by the C³ business.

Canopy Growth Divests Its CBD Subsidiary To European Pharma Co. For 80M Euros

Canopy Growth Corp. CGC, -1.72% WEED, -1.67% said Wednesday it agreed to sell its Cannabinoid Compound Company GmbH (C3) to Dermapharm Holding SE for up to 122.6 million euros ($138 million). Canopy Growth said the transaction will reduce its short-term capital investment requirements by more than $38.9 million.

Canopy Growth Corp sells German unit to Dermapharm Holding SE

Sale supports the Company's strategic focus on driving demand for cannabis and cannabinoid-based consumer products SMITHS FALLS, ON and NEUMARKT-IN-DER-OBERPFALZ, Germany, Dec. 15, 2021 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH ("C3"), to Dermapharm Holding SE ("Dermapharm") (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany. The C³ business develops and manufactures pharmaceutical products and is comprised of Spectrum Therapeutics GmbH, based in Neumarkt-in-der-Oberpfalz, Germany, THC Pharm GmbH The Health Concept, based in Frankfurt, Germany, and Spectrum Therapeutics Austria GmbH, based in Vienna, Austria.

Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company

High Tide

Top Pot Stocks For Your 2022 Watchlist The post Top Canadian Marijuana Stocks To Buy? 2 To Watch Right Now In December appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks To Buy? 2 To Watch Right Now In December

Cannabis Growth ETF

Amplify Seymour Cannabis ETF

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

Amplify US Alternative Harvest ETF

MedMen Enterprises Inc.

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

Advisorshares Poseidon Dynamic Cannabis ETF

Constellation Brands

Trulieve Cannabis Corp.

AXS Cannabis ETF

Tilray Brands

AdvisorShares Pure Cannabis ETF 

Edifying episode with industry expert Brady Cobb. Recent cannabis legislation; moving from optics to real reform. SAFE Banking, uplisting and what it all means for cannabis investors

Cannabis Stocks Are A Coiled Spring - Brady Cobb's Industry Update (Podcast Transcript)

Aurora Cannabis

Wells Fargo just shouted "sell!" -- but investors bought cannabis stocks instead.

Why Tilray, Aurora Cannabis, and Canopy Growth Are Glowing Green

GrowGeneration Corp

Hydrofarm Holdings Group

Scotts Miracle-Gro

Wells Fargo analyst Chris Carey on Thursday initiated coverage of four cannabis stocks, with Scotts Miracle-Gro Co. drawing the most bullish comments, in a sign of Wall Street's growing interest in the sector.

The Ratings Game: Wells Fargo launches coverage of four cannabis stocks

SNDL Inc.

Canadian marijuana stocks didn't fare well this week.

Why Pot Stocks Canopy Growth, Sundial Growers, and Tilray All Had a Rough Week

AFC Gamma

Agrify

Arena Pharmaceuticals

Alpine Global Premier Properties Fund

Cambria Global Real Estate ETF

Clever Leaves Holdings Inc

Cardiol Therapeutics

Cronos Group

Charlotte's Web Holdings, Inc.

Direxion Daily CSI China Internet Index Bull 2X Shares

WisdomTree Global ex-US Real Estate Fund

Invesco S&P 500 Equal Weight Real Estate ETF

First Trust FTSE EPRA/NAREIT Developed Markets Real Estate

Fidelity MSCI Real Estate ETF

First Trust S&P REIT Index Fund

Greenlane Holdings

FlexShares Global Quality Real Estate Index Fund

Xtrackers International Real Estate ETF

High on Growth: Cannabis REITs are far-and-away the best-performing REIT sector of the past half-decade as the budding industry thrives in the murky and often contradictory regulatory framework of legalized marijuana. Joining Innovative Industrial, Power REIT, and AFC Gamma, a pair of newcomers will soon enter the pot party - Chicago Atlantic Real Estate Finance and Freehold Properties - both operating as mortgage REITs.

Cannabis REITs: When They Go Low, We Get High

Monster Beverage

Village Farms International

CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.

Should You Buy Beaten Down Cannabis Stocks & ETFs Now?

It's all about having the widest opportunities to pursue growth.

Here's Why Former Canopy Growth CEO Bruce Linton Thinks Cannabis Stocks Should Get Off the Major Exchanges

OrganiGram Holdings Inc.

Current Trading Levels For Canadian Pot Stocks Could Be Worth Watching The post Looking For Marijuana Stocks To Buy While Cannabis Stocks Are Down? 2 Canadians For Your List Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Looking For Marijuana Stocks To Buy While Cannabis Stocks Are Down? 2 Canadians For Your List Right Now

Cerence

GameStop

Coca-Cola

Pinterest

PayPal

The Monster Beverage-Constellation news and other market happenings.

Is a Monster Merger Brewing?

You would have been better off investing in the S&P 500.

If You Invested $100,000 in Canopy Growth When Canada Legalized Marijuana, This Is How Much You'd Have Right Now

U.S. legalization is still stalled, but Mexican marijuana legalization could be imminent.

Why Aurora Cannabis, Canopy Growth, and Tilray Stocks Dropped Today

Anheuser-Busch InBev

Molson Coors Brewing

Cannabis is a losing ball game – because you get into price wars where everyone loses. But the psychedelics industry has built-in competitive moats that differentiate it from pot.

The Reason I Was Wrong on Pot Stocks Is Why I'm Right About This

Canopy Growth vs. Aurora Cannabis: Which Company Had Better Earnings?

Timely, edifying episode with industry expert Brady Cobb. Recent cannabis legislation; moving from optics to real reform. SAFE Banking, uplisting and what it all means for cannabis investors.

Cannabis Stocks Are A Coiled Spring - Industry Update With Brady Cobb (Podcast)

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP) has brought in the experts to assess the potential of the cannabinoid library licensed from the North American cannabis giant, Canopy Growth. It has access to 335 derivatives of the naturally occurring compounds found in cannabis plants.

Oxford Cannabinoid Technologies brings in a specialist R&D firm to help it unlock the potential of Canopy Growth library

Entegris

Intercure Ltd

Neptune Wellness Solutions Inc.

Spotify

Teradyne

cbdMD Inc

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.

It's Been a Blazing Hot Week for These 12 Cannabis Stocks

Canopy Growth Corp. CGC, -9.19% WEED, -9.32% on Friday named Judy Hong as interim chief financial officer and Tara Rozalowsky as interim chief product officer and launched an external search for both roles. Mike Lee, executive vice president and CFO and chief product officer Rade Kovacevic will depart the company on Dec. 31.

Canopy Growth names interim CFO and launches search for two key executives

Changes are designed to drive execution against the Company's strategic priorities SMITHS FALLS, ON, Nov. 19, 2021 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, hemp, and cannabis device company, today announced strategic changes to its Executive Management Committee. Effective immediately, Mike Lee, Executive Vice President and Chief Financial Officer, and Rade Kovacevic, President and Chief Product Officer will be stepping down from their respective roles on the Executive Management Committee and will depart from the company on December 31, 2021.

Canopy Growth Announces Changes to Executive Management Team

HEXO Corp

Recent comments from would-be pot law reformers in the U.S. Congress aren't exactly heartening.

Why Canadian Pot Stocks, Like Sundial Growers, Are Falling Today

An analyst initiated coverage on three of the stocks, but all of them fell as a result.

Why Canopy Growth, Cronos, Hexo, Sundial, and Tilray Stocks Are Plunging This Week

Barclays has issued a report that has cast doubt over an entire industry and has sent cannabis stocks plunging. Should you be worried?

Cannabis Stocks: How One Analyst Just Snuffed Out TLRY, CRON, CGC Stocks

News for Canopy Growth Stock (CGC)